CLO25-076: CD13 as a Potential Membrane Marker in PSMA-Negative Prostate Cancer and First-in-Human Study of [18F]AlF-CD13-L1 PET/CT Imaging
"CLO25-076: CD13 as a Potential Membrane Marker in PSMA-Negative Prostate Cancer and First-in-Human Study of [18F]AlF-CD13-L1 PET/CT Imaging" published on 28 Mar 2025 by National Comprehensive Cancer Network.
Authors
- Yi Cai
- Xiaomei Gao (ORCID: https://orcid.org/0000-0002-9247-5825)
- Yongxiang Tang (ORCID: https://orcid.org/0000-0003-3987-8702)
- Shuo Hu (ORCID: https://orcid.org/0000-0003-0998-8943)
- Ming Zhou
- Wei Tang
- Lin Qi (ORCID: https://orcid.org/0000-0002-4587-8226)
- Ye Zhang (ORCID: https://orcid.org/0000-0002-6715-7884)
- Chenxi Lu
Institutions
- Central South University (CN)
- Xiangya Hospital Central South University (CN)
Publication Details
- Journal
- Journal of the National Comprehensive Cancer Network
- Published
- 2025-03-28
- DOI
- https://doi.org/10.6004/jnccn.2024.7100
- Primary Topic
- Prostate Cancer Treatment and Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00